Displaying drugs 3126 - 3150 of 3197 in total
Flurandrenolide acetate
Experimental
PCO-371
PCO-371 is under investigation in clinical trial NCT02475616 (A Single Ascending Dose Study of PCO371 in Healthy Volunteers).
Investigational
Ascorbyl glucoside
Experimental
Reidispongiolide A
Experimental
Monastrol
Experimental
CHROMOPHORE (ASP-TYR-GLY)
Experimental
Atrasentan
Atrasentan is a substance that is being studied in the treatment of cancer. It belongs to the family of drugs called endothelin-1 protein receptor antagonists. It is a novel, selective endothelin A receptor antagonist (SERA).
Investigational
BMS-275183
BMS-275183 has been used in trials studying the treatment of Tumors and Non-small Cell Lung Cancer.
Investigational
Razupenem
Razupenem has been used in trials studying the treatment of Skin Infections.
Investigational
Flurithromycin
Experimental
Cannabinor
Cannabinor, a synthetic CB2-selective agonist, is in Phase 2 clinical testing as an analgesic.
Investigational
Lanatoside C
Experimental
Sphinxolide B
Experimental
Uridine-Diphosphate-N-Acetylgalactosamine
Experimental
Uridine-Diphosphate-N-Acetylglucosamine
Experimental
D-Eritadenine
Experimental
Nelivaptan
Nelivaptan has been used in trials studying the treatment of Anxiety Disorders, Depressive Disorder, and Major Depressive Disorder.
Investigational
JTK-853
JTK-853 has been used in trials studying the treatment of Hepatitis C Virus Infection, Response to Therapy of.
Investigational
Displaying drugs 3126 - 3150 of 3197 in total